Newer markers in cancer

Carcinoma: cytokeratin

Sarcoma: desmin / vimentin

Malignant polycythemia rubra vera: V617F JAK2 mutation

FLT3 mutation predicts prognosis in AML

Chromosome 13 abnormality will indicate poor response to conventional treatment in multiple myeloma

Add a Comment

Your email address will not be published. Comments will be displayed only after moderation.

Read previous post:
FISH – Acronym

Flourescent in situ hybridisation